Dtap vaccine and prednisone
Churchill Livingstone Elsevier; For specific immunocompromising conditions e. Anatomical or functional asplenia that are indications for pneumococcal vaccination are sickle cell disease and other hemoglobinopathies, congenital or acquired asplenia, splenic dysfunction, and splenectomy.
Special populations Pregnant women who do not have evidence of immunity to rubella should receive 1 dose of MMR upon completion or termination of pregnancy and before discharge from the healthcare facility; non-pregnant women of childbearing age without evidence of rubella immunity should receive 1 dose of MMR. If not administered on the same day, these vaccines should be separated by at least 28 days.
Subscribe to receive email notifications whenever new articles are published. Not a Medscape Member?
If testing cannot be performed until after the day of MMR vaccination, the test should be postponed for at least 4 weeks after the vaccination. The decision to administer or delay vaccination because of a current or recent acute illness depends on the severity of symptoms and etiology of the condition. For children who are severely immunocompromised or who are infected with HIV, DTP vaccine is indicated in the same schedule and dose as for immunocompetent children, including the use of acellular pertussis-containing vaccines DTaP as a booster.
Use the arrow keys to navigate suggestions.
Search for questions
Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings, including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations, long-term care facilities, industry and academia.
N Engl J Med. If the immunosuppressed state can be anticipated, vaccinating first is the best opportunity for a positive immunologic response. Acknowledgment of a specific risk factor by those who seek protection is not needed Special populations Adults with any of the following indications should receive a HepA series: Adults who received inactivated killed measles vaccine or measles vaccine of unknown type during years — should be revaccinated with 1 or 2 doses of MMR.
Special populations Adults aged 19 through 64 years with chronic heart disease including congestive heart failure and cardiomyopathies excluding hypertension ; chronic lung disease including chronic obstructive lung disease, emphysema, and asthma; chronic liver disease including cirrhosis; alcoholism; or diabetes mellitus; or who smoke cigarettes should receive PPSV For adults aged 56 years or older who have not previously received serogroups A, C, W, and Y meningococcal vaccine and need only 1 dose, meningococcal polysaccharide serogroups A, C, W, and Y vaccine MPSV4 is preferred.
Severe Combined Immunodeficiency SCID disease and a history of intussusception are both contraindications to the receipt of rotavirus vaccines 6. Until these questions have been answered, it is best to continue with standard annual influenza vaccination in most patients. One dose may be insufficient to induce immunity in children greater than 5 years of age with sickle cell disease, but the data are insufficient to recommend whether persons suffering from this or other immunosuppressive disorders should receive more than one dose.
Nephrotic syndrome is the renal disease most clearly associated with an increased risk for pneumococcal infection. Attenuated measles vaccine in children with acute leukemia.
To view content sources and attributions, please refer to our editorial policy. Report suspected cases of reportable vaccine-preventable diseases to the local or state health department. Persons without evidence of immunity for whom VAR should be emphasized are: If you are currently being treated or have recently been treated with predniSONE, you should let your doctor know before receiving tetanus toxoid.
Hib should be administered at least 14 days before splenectomy.